GlycoEra

Description: GlycoEra develops glycoengineered therapeutics using its CustomGlycan platform to treat challenging diseases by targeting glycan-mediated biology.

Country: Switzerland

Based in: Schlieren

Founded: 2020

Funding Stage: Seed

Tags: ['Biotechnology', 'Information Technology', 'Life Science']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.